CLINICAL_TRIALS trial_result · 2023-03-07

Clinical Trial Update: "FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM) [NA]

Completed feasibility trial of an extended wear continuous subcutaneous insulin infusion set for adults with type 1 diabetes; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Capillary Biomedical, Inc. | Conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2023-03-07